Endonovo Therapeutics Announces Eight Additional Hospitals Approved Use of SofPulse® at Their Facilities
April 16, 2020 08:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, April 16, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the addition of eight new hospitals Endonovo’s SofPulse®...
Endonovo Therapeutics seeks Intensive Care Unit Partners for Investigational Adjunctive Treatment for Severe Respiratory Inflammatory Complications for COVID-19 Patients.
March 25, 2020 08:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 25, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announces the intent to distribute of SofPulse®...
Endonovo to Donate SofPulse® Units for Investigational Use to Evaluate Inhibition of Inflammatory Symptoms Associated with COVID-19
March 16, 2020 08:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 16, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced it will donate SofPulse® devices to Intensive Care Units...
Endonovo Therapeutics Files 8K With SEC Regarding SofPulse®
March 02, 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, March 02, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced it has filed an 8K with the Securities and Exchange...
Endonovo Therapeutics Introduces Support of SofPulse® With A New Ancillary Multi-Use Patient Brace From Protex
February 24, 2020 13:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced the production and introduction of an ancillary multi-use...
Endonovo Therapeutics Begins Process For Medical Reimbursements
February 20, 2020 11:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced undertaking initial steps for obtaining medical...
Endonovo Therapeutics Announces collaborating with a Stanford University sponsored Orthopedic Shoulder and Knee Study
February 13, 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 13, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced Endonovo Therapeutics is collaborating with a Stanford...
Endonovo Therapeutics announces its collaboration with Major Universities for the Evaluation of SofPulse® for Orthopedic Surgeries
February 10, 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 10, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced their SofPulse® device is being evaluated at major...
Endonovo Therapeutics Reduces Debt
February 04, 2020 07:30 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Feb. 04, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") is pleased to announce the reduction of current liabilities and...
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
January 30, 2020 07:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...